Abstract | PURPOSE: PATIENTS AND METHODS: Prospectively collected patient data from 2 institutions was used to identify all adult patients (>or=16 years) with >or=5 cm, deep, primary, extremity, synovial sarcoma that underwent surgical treatment of cure from 1990 to 2002. A total of 101 patients were identified and the median follow-up for survivors was 58 months. Clinical, pathologic, and treatment variables were analyzed for disease-specific survival (DSS), distant recurrence-free survival (DRFS), and local recurrence-free survival (LRFS). RESULTS: Sixty-eight (67%) patients were treated with IF and 33 (33%) patients received no chemotherapy (NoC) for the primary tumor. The characteristics of the IF-treated patients [median tumor size = 7.2 cm; monophasic n = 46 (68%)] were similar to NoC patients [median tumor size = 7 cm; monophasic n = 23 (70%)]. The 4-year DSS of the IF-treated patients was 88% compared with 67% for the NoC patients (P = 0.01). Smaller size (HR = 0.3 per 5-cm decrease, P < 0.0001) and treatment with IF (HR = 0.3 compared with NoC, P = 0.007) were independently associated with an improved DSS. Treatment with IF was independently associated with an improved DRFS (HR = 0.4, P = 0.03) but not associated with an improved LRFS (P = 0.39). CONCLUSION:
Ifosfamide-based chemotherapy was associated with an improved DSS in adult patients with high-risk, primary, extremity, synovial sarcoma and should be considered in the treatment of such patients.
|
Authors | Fritz C Eilber, Murray F Brennan, Frederick R Eilber, Jeffery J Eckardt, Stephen R Grobmyer, Elyn Riedel, Charles Forscher, Robert G Maki, Samuel Singer |
Journal | Annals of surgery
(Ann Surg)
Vol. 246
Issue 1
Pg. 105-13
(Jul 2007)
ISSN: 0003-4932 [Print] United States |
PMID | 17592298
(Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibiotics, Antineoplastic
- Antineoplastic Agents, Alkylating
- Doxorubicin
- Ifosfamide
|
Topics |
- Adolescent
- Adult
- Aged
- Antibiotics, Antineoplastic
(therapeutic use)
- Antineoplastic Agents, Alkylating
(therapeutic use)
- Arm
- Disease-Free Survival
- Doxorubicin
(therapeutic use)
- Female
- Follow-Up Studies
- Humans
- Ifosfamide
(therapeutic use)
- Leg
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(mortality)
- Prospective Studies
- Sarcoma, Synovial
(drug therapy, mortality)
- Survival Rate
(trends)
- Treatment Outcome
|